C Abrams
Overview
Explore the profile of C Abrams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morrow L, Abrams C, Shaw A
J R Nav Med Serv
. 2018 Aug;
103(1):5-9.
PMID: 30088730
In 2015 HMS DUNCAN was chosen as the intervention ship for an Institute of Naval Medicine (INM)-led project entitled Second
Sea Lord (2SL)’s Feeding the Fleet Initiative. During her nine-month...
2.
Hoots W, Abrams C, Tankersleydagger D
Transfus Med Rev
. 2001 Jul;
15(2 Suppl 1):45-59.
PMID: 11441420
Although the true risk of transmitting (classical) Creutzfeld-Jakob Disease (CJD) and variant CJD (vCJD) via transfusion is likely very minimal, a review of prions and the impact of these associated...
3.
Fischer G, Hoots W, Abrams C
Transfus Med Rev
. 2001 Jul;
15(2 Suppl 1):27-39.
PMID: 11441418
Viral reduction techniques help assure the highest level of plasma-product safety that is possible using today's technology. However, worldwide travel and changing demographics could bring new pathogens into focus and...
4.
Hoots W, Abrams C, Tankersley D
Transfus Med Rev
. 2001 Jul;
15(2 Suppl 1):20-6.
PMID: 11441417
The balance between acceptable plasma-product safety and the demand for those products involves a finite (but very low) level of risk for transmitting infectious diseases. The Food and Drug Administration...
5.
Meadows K, Abrams C, Sandbaek A
Diabet Med
. 2000 Nov;
17(8):572-80.
PMID: 11073178
Aims: To adapt the Diabetes Health Profile (DHP-1) for use with English speaking patients with Type 2 diabetes mellitus and to evaluate the psychometric properties of the adapted measure in...
6.
Pfeifer M, Begerow B, Minne H, Abrams C, Nachtigall D, Hansen C
J Bone Miner Res
. 2000 Jun;
15(6):1113-8.
PMID: 10841179
Long-term vitamin D and calcium supplementation is effective in reducing nonvertebral fractures in elderly people. Increased bone fragility caused by secondary hyperparathyroidism (sHPT) and impaired balance are known risk factors...
7.
Abrams C
MLO Med Lab Obs
. 2000 May;
32(2):24-8, 30, 32-3; quiz 36, 38.
PMID: 10787887
No abstract available.
8.
Lee D, Gornbein J, Abrams C
J Ocul Pharmacol Ther
. 2000 Feb;
16(1):3-18.
PMID: 10673126
The purpose of this study was to determine the effectiveness and safety of brimonidine 0.2% (Alphagan, Allergan Inc., Irvine, CA) as mono-, combination, or replacement therapy for reducing intraocular pressure...
9.
Weiner J, Tucker A, Collins A, Fakhraei H, Lieberman R, Abrams C, et al.
J Ambul Care Manage
. 1999 Jul;
21(4):29-52.
PMID: 10387436
This article describes the risk-adjusted payment methodology employed by the Maryland Medicaid program to pay managed care organizations. It also presents an empirical simulation analysis using claims data from 230,000...
10.
Molino M, Blanchard N, Belmonte E, Tarver A, Abrams C, Hoxie J, et al.
J Biol Chem
. 1995 May;
270(19):11168-75.
PMID: 7744748
Cathepsin G is a neutrophil-derived protease that has been shown to inhibit the effects of thrombin on some cells expressing thrombin receptors while acting as an agonist on others. The...